These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 23684627)

  • 21.
    Olsen I; Lambris JD; Hajishengallis G
    J Oral Microbiol; 2017; 9(1):1340085. PubMed ID: 28748042
    [No Abstract]   [Full Text] [Related]  

  • 22. Breaking bad: manipulation of the host response by Porphyromonas gingivalis.
    Hajishengallis G; Lamont RJ
    Eur J Immunol; 2014 Feb; 44(2):328-38. PubMed ID: 24338806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New developments in neutrophil biology and periodontitis.
    Hajishengallis G
    Periodontol 2000; 2020 Feb; 82(1):78-92. PubMed ID: 31850633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Boolean Network Approach to Study the Mechanism Associated with Inflammatory Response Induced by
    Gasmi Benahmed A; Noor S; Menzel A; Gasmi A
    Arch Razi Inst; 2023 Feb; 78(1):1-7. PubMed ID: 37312726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Porphyromonas gingivalis neutrophil manipulation: risk factor for periodontitis?
    Darveau RP
    Trends Microbiol; 2014 Aug; 22(8):428-9. PubMed ID: 25001854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The complement system and its role in the pathogenesis of periodontitis: current concepts.
    Damgaard C; Holmstrup P; Van Dyke TE; Nielsen CH
    J Periodontal Res; 2015 Jun; 50(3):283-93. PubMed ID: 25040158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Porphyromonas gingivalis virulence factors involved in subversion of leukocytes and microbial dysbiosis.
    Zenobia C; Hajishengallis G
    Virulence; 2015; 6(3):236-43. PubMed ID: 25654623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune evasion strategies of Porphyromonas gingivalis.
    Hajishengallis G
    J Oral Biosci; 2011; 53(3):233-240. PubMed ID: 22162663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement modulates the cutaneous microbiome and inflammatory milieu.
    Chehoud C; Rafail S; Tyldsley AS; Seykora JT; Lambris JD; Grice EA
    Proc Natl Acad Sci U S A; 2013 Sep; 110(37):15061-6. PubMed ID: 23980152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the microbiota in periodontal disease.
    Curtis MA; Diaz PI; Van Dyke TE
    Periodontol 2000; 2020 Jun; 83(1):14-25. PubMed ID: 32385883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Metalloproteinase Mirolysin of Tannerella forsythia Inhibits All Pathways of the Complement System.
    Jusko M; Potempa J; Mizgalska D; Bielecka E; Ksiazek M; Riesbeck K; Garred P; Eick S; Blom AM
    J Immunol; 2015 Sep; 195(5):2231-40. PubMed ID: 26209620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral treatment with complement factor C5a receptor (CD88) antagonists inhibits experimental periodontitis in rats.
    Breivik T; Gundersen Y; Gjermo P; Taylor SM; Woodruff TM; Opstad PK
    J Periodontal Res; 2011 Dec; 46(6):643-7. PubMed ID: 21722134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Linkage of Periodontitis and Rheumatoid Arthritis: Current Evidence and Potential Biological Interactions.
    de Molon RS; Rossa C; Thurlings RM; Cirelli JA; Koenders MI
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540277
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Hajishengallis G; Diaz PI
    Curr Oral Health Rep; 2020 Mar; 7(1):12-21. PubMed ID: 33344104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of Thiopeptide antibiotics on inflammatory responses in periodontal tissues through the regulation of the MAPK pathway.
    Lyu J; Shen S; Hao Y; Zhou M; Tao J
    Int Immunopharmacol; 2024 May; 133():112094. PubMed ID: 38652969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An update on periodontal inflammation and bone loss.
    Zhang M; Liu Y; Afzali H; Graves DT
    Front Immunol; 2024; 15():1385436. PubMed ID: 38919613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TLR2 promoter hypermethylation creates innate immune dysbiosis.
    Benakanakere M; Abdolhosseini M; Hosur K; Finoti LS; Kinane DF
    J Dent Res; 2015 Jan; 94(1):183-91. PubMed ID: 25389002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cleavage of the human C5A receptor by proteinases derived from Porphyromonas gingivalis: cleavage of leukocyte C5a receptor.
    Jagels MA; Ember JA; Travis J; Potempa J; Pike R; Hugli TE
    Adv Exp Med Biol; 1996; 389():155-64. PubMed ID: 8861006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutrophils in the periodontium: Interactions with pathogens and roles in tissue homeostasis and inflammation.
    Uriarte SM; Hajishengallis G
    Immunol Rev; 2023 Mar; 314(1):93-110. PubMed ID: 36271881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maintaining homeostatic control of periodontal bone tissue.
    Hathaway-Schrader JD; Novince CM
    Periodontol 2000; 2021 Jun; 86(1):157-187. PubMed ID: 33690918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.